Carbamazepine diminishing the effects of warfarin and leading to mesenteric embolism in a patient with atrial fibrillation.

被引：0
|
作者：
Karcic, E
Karcic, AA
机构：
[1] St Louis Univ, Sch Med, Dept Geriatr, St Louis, MO USA
[2] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA
[3] Nassau Cty Med Ctr, E Meadow, NY 11554 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2000年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] Carbamazepine diminishing the effects of warfarin and leading to mesenteric embolism in a patient with atrial fibrillation.
    Karcic, E
    Karcic, AA
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 : 36 - 36
  • [2] Carbamazepine diminishing the effects of warfarin and leading to mesenteric embolism in a patient with arterial fibrillation
    Karcic, E
    Karcic, AA
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (02) : 229A - 229A
  • [3] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12): : 1139 - 1151
  • [4] Dabigatran versus warfarin in patients with atrial fibrillation.
    Lundelin, K.
    REVISTA CLINICA ESPANOLA, 2010, 210 (03): : 139 - 140
  • [5] Exploring patient satisfaction with long-term warfarin for the treatment of atrial fibrillation.
    Murray, M
    Wild, D
    Reaney, M
    BLOOD, 2005, 106 (11) : 632A - 633A
  • [6] Cost-effectiveness of warfarin pharmacogenomics in atrial fibrillation.
    Leey, J.
    McCabe, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S146 - S146
  • [7] Acute mesenteric ischemia due to superior mesenteric artery embolism in a patient with permanent atrial fibrillation
    Simunic, Miroslav
    Fabijanic, Damir
    Perkovic, Nikola
    Bogdanovic, Zoran
    Maras-Simunic, Marina
    Batinic, Tonci
    Tonkic, Ante
    SIGNA VITAE, 2010, 5 (01) : 40 - 43
  • [8] Patient preference and capabilities are at least as important as clinical contraindications as barriers to prescribing warfarin in patients with atrial fibrillation.
    Hollowell, J
    Ingelgard, A
    Reddy, P
    Gold, K
    Fitzmaurice, D
    BLOOD, 2004, 104 (11) : 606A - 606A
  • [9] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [10] Patient-Reported Triggers of Paroxysmal Atrial Fibrillation.
    Groh, Christopher A.
    Faulkner, Madelaine
    Getabecha, Shiffen
    Taffe, Victoria
    Nah, Gregory
    Sigona, Kathi
    McCall, Debbe
    Hills, Mellanie True
    Sciarappa, Kathleen
    Pletcher, Mark J.
    Olgin, Jeffrey E.
    Marcus, Gregory M.
    CIRCULATION, 2018, 138
12345